iShares Nasdaq Biotechnology (IBB) Poised to Open Up Over 2%
iShares Nasdaq Biotechnology (NASDAQ: IBB) is poised to open higher by over 2%. Top holdings in the ETF are Biogen Idec (NASDAQ: BIIB), Celgene (NASDAQ: CELG), Gilead Sciences (NASDAQ: GILD), Amgen (NASDAQ: AMGN), and Regeneron (NASDAQ: REGN).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US stocks saw largest 2-week outflow since December 2022 - BofA
- Blackstone (BX) Nears Deal to Sell Control of S.Korean Pharma Wholesaler Geo-young to MBK Parnters for Over $1B - Reuters
- CSX Corp. (CSX) Shares Trade Lower Ahead of Results, Down 2.2%
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!